Kozo Oka
Shonan Health Innovation Park
Fujisawa, Japan
Fujisawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MicroRNA-33 inhibition ameliorates muscular dystrophy by enhancing skeletal muscle regeneration.
Journal: EMBO molecular medicine
Published: February 27, 2025
A monoclonal antibody activating AdipoR for type 2 diabetes and nonalcoholic steatohepatitis.
Journal: Science advances
Published: November 10, 2023
Increased neurotoxicity of high-density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very-long-chain fatty acid transporter Abcd1.
Journal: Journal of inherited metabolic disease
Published: August 23, 2023
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis.
Journal: Life science alliance
Published: January 05, 2023
Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy.
Journal: Biological & pharmaceutical bulletin
Published: November 03, 2022
Inhibition of microRNA-33b specifically ameliorates abdominal aortic aneurysm formation via suppression of inflammatory pathways.
Journal: Scientific reports
Published: February 27, 2022
Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients.
Journal: Biology open
Published: April 27, 2019
The effect of combined treatment with canagliflozin and teneligliptin on glucose intolerance in Zucker diabetic fatty rats.
Journal: Journal of pharmacological sciences
Published: January 19, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026